Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED BALANCE SHEETS

v3.19.2
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)
Jun. 30, 2019
Mar. 31, 2019
CURRENT ASSETS    
Cash $ 2,492,354 $ 3,828,074
Prepaid expenses and other current assets 151,717 210,042
TOTAL CURRENT ASSETS 2,644,071 4,038,116
Property and equipment, net 6,330 6,021
Right-of-use lease asset 205,968 0
Patents, net 64,377 66,668
Deposits 12,159 12,159
TOTAL ASSETS 2,932,905 4,122,964
CURRENT LIABILITIES    
Accounts payable 276,116 131,931
Due to related parties 94,442 83,654
Convertible notes payable, net 892,591 962,301
Lease liability, current portion 93,077 0
Other current liabilities 441,228 646,000
TOTAL CURRENT LIABILITIES 1,797,454 1,823,886
Lease liability, less current portion 117,259 0
TOTAL LIABILITIES 1,914,713 1,823,886
COMMITMENTS AND CONTINGENCIES (Note 13)
STOCKHOLDERS' EQUITY    
Common stock, par value $0.001 per share; 30,000,000 shares authorized; 19,103,570 and 19,004,253 shares issued and outstanding as of June 30, 2019 and March 31, 2019, respectively 19,104 19,004
Additional paid-in capital 108,844,836 108,058,538
Accumulated deficit (107,718,857) (105,652,433)
TOTAL AETHLON MEDICAL, INC. STOCKHOLDERS' EQUITY BEFORE NONCONTROLLING INTERESTS 1,145,083 2,425,109
NONCONTROLLING INTERESTS (126,891) (126,031)
TOTAL STOCKHOLDERS' EQUITY 1,018,192 2,299,078
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY $ 2,932,905 $ 4,122,964